Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts

Toxicology in Vitro

Volumn 26, Issue 2, 2012, Pages 323-334

  Wilhelmi, Verena ^a   Fischer, Ute ^b   van Berlo, Damiën ^a   Schulze Osthoff, Klaus ^c   Schins, Roel P F ^a   Albrecht, Catrin ^a  

^a IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; Assay validation; In vitro testing; Nanoparticles; Necrosis

Indexed keywords

CASPASE 3; CASPASE 7; LACTATE DEHYDROGENASE; MAGNESIUM OXIDE; NANOPARTICLE; PHOSPHATIDYLSERINE; SILICON DIOXIDE; STAUROSPORINE; TITANIUM DIOXIDE; ZINC OXIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IN VITRO STUDY; MACROPHAGE; MOUSE; NANOTOXICOLOGY; NONHUMAN;

ANIMALS; APOPTOSIS; ARTIFACTS; BIOLOGICAL ASSAY; CASPASE 3; CASPASE 7; CELL LINE; CELL SURVIVAL; DNA FRAGMENTATION; MACROPHAGES; MAGNESIUM OXIDE; MICE; NANOPARTICLES; SILICON DIOXIDE; TITANIUM; ZINC OXIDE;

EID: 84856456145     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.12.006     Document Type: Article

References (41)

1. Albrecht C., Borm P.J., Adolf B., Timblin C.R., Mossman B.T. In vitro and in vivo activation of extracellular signal-regulated kinases by coal dusts and quartz silica. Toxicol. Appl. Pharmacol. 2002, 184:37-45.
2. Albrecht C., Knaapen A.M., Becker A., Hohr D., Haberzettl P., van Schooten F.J., Borm P.J., Schins R.P. The crucial role of particle surface reactivity in respirable quartz-induced reactive oxygen/nitrogen species formation and APE/Ref-1 induction in rat lung. Respir. Res. 2005, 6:129.
3. Auffan M., Rose J., Wiesner M.R., Bottero J.Y. Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro. Environ. Pollut. 2009, 157:1127-1133.
4. Balbus J.M., Maynard A.D., Colvin V.L., Castranova V., Daston G.P., Denison R.A., Dreher K.L., Goering P.L., Goldberg A.M., Kulinowski K.M., Monteiro-Riviere N.A., Oberdorster G., Omenn G.S., Pinkerton K.E., Ramos K.S., Rest K.M., Sass J.B., Silbergeld E.K., Wong B.A. Meeting report: hazard assessment for nanoparticles - Report from an interdisciplinary workshop. Environ. Health Perspect. 2007, 115:1654-1659.
5. Borges V.M., Falcao H., Leite-Junior J.H., Alvim L., Teixeira G.P., Russo M., Nobrega A.F., Lopes M.F., Rocco P.M., Davidson W.F., Linden R., Yagita H., Zin W.A., DosReis G.A. Fas ligand triggers pulmonary silicosis. J. Exp. Med. 2001, 194:155-164.
6. BSi_report, 2007. PAS 136 terminology for nanomaterials. http://www.bsigroup.com/upload/standards%20&%20Publications/Nanotechnologies/PAS%20136.pdf.
7. Chaudhry Q., Scotter M., Blackburn J., Ross B., Boxall A., Castle L., Aitken R., Watkins R. Applications and implications of nanotechnologies for the food sector. Food Addit Contam Part A Chem. Anal. Control Expo. Risk Assess. 2008, 25:241-258.
8. Cho W.S., Duffin R., Poland C.A., Duschl A., Oostingh G.J., Macnee W., Bradley M., Megson I.L., Donaldson K. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 2011.
9. Donaldson K., Stone V., Tran C.L., Kreyling W., Borm P.J. Nanotoxicology. Occup. Environ. Med. 2004, 61:727-728.
10. Duffin R., Mills N.L., Donaldson K. Nanoparticles - A thoracic toxicology perspective. Yonsei Med. J. 2007, 48:561-572.
11. Fischer U., Stroh C., Schulze-Osthoff K. Unique and overlapping substrate specificities of caspase-8 and caspase-10. Oncogene 2006, 25:152-159.
12. Fubini B. Surface chemistry and quartz hazard. Ann. Occup. Hyg. 1998, 42:521-530.
13. Fubini B., Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic. Biol. Med. 2003, 34:1507-1516.
14. Hanley C., Layne J., Punnoose A., Reddy K.M., Coombs I., Coombs A., Feris K., Wingett D. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Nanotechnology 2008, 19:295103.
15. Iyer R., Hamilton R.F., Li L., Holian A. Silica-induced apoptosis mediated via scavenger receptor in human alveolar macrophages. Toxicol. Appl. Pharmacol. 1996, 141:84-92.
16. Johnston C.J., Driscoll K.E., Finkelstein J.N., Baggs R., O'Reilly M.A., Carter J., Gelein R., Oberdorster G. Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. Toxicol. Sci. 2000, 56:405-413.
17. Johnston H.J., Hutchison G.R., Christensen F.M., Peters S., Hankin S., Stone V. Identification of the mechanisms that drive the toxicity of TiO(2)particulates: the contribution of physicochemical characteristics. Part Fibre Toxicol. 2009, 6:33.
18. Kim H., Ahn E.-K., Jee B., Yoon H.-K., Lee K., Lim Y. Nanoparticulate-induced toxicity and related mechanism in vitro and in vivo. J.Nanoparticle Res. 2009, 11:55-65.
19. Kroll A., Pillukat M.H., Hahn D., Schnekenburger J. Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur. J. Pharm. Biopharm. 2009, 72:370-377.
20. Krysko D.V., Vanden Berghe T., D'Herde K., Vandenabeele P. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 2008, 44:205-221.
21. Monteiro-Riviere N.A., Inman A.O., Zhang L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 2009, 234:222-235.
22. Napierska D., Thomassen L.C., Lison D., Martens J.A., Hoet P.H. The nanosilica hazard: another variable entity. Part Fibre Toxicol. 2010, 7:39.
23. Oberdorster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005, 2:8.
24. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
25. Ortiz L.A., Moroz K., Liu J.Y., Hoyle G.W., Hammond T., Hamilton R.F., Holian A., Banks W., Brody A.R., Friedman M. Alveolar macrophage apoptosis and TNF-alpha, but not p53, expression correlate with murine response to bleomycin. Am. J. Physiol. 1998, 275:L1208-1218.
26. Powell J.J., Faria N., Thomas-McKay E., Pele L.C. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J. Autoimmun. 2010, 34:J226-233.
27. Rahman Q., Lohani M., Dopp E., Pemsel H., Jonas L., Weiss D.G., Schiffmann D. Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts. Environ. Health Perspect. 2002, 110:797-800.
28. Riss T.L., Moravec R.A. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev. Technol. 2004, 2:51-62.
29. Riviere G. European and international standardisation progress in the field of engineered nanoparticles. Inhal. Toxicol. 2009, 21(Suppl 1):2-7.
30. Sarih M., Souvannavong V., Brown S.C., Adam A. Silica induces apoptosis in macrophages and the release of interleukin-1 alpha and interleukin-1 beta. J. Leukoc. Biol. 1993, 54:407-413.
31. Silva M.T. Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett. 2010, 584:4491-4499.
32. Sohaebuddin S.K., Thevenot P.T., Baker D., Eaton J.W., Tang L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol. 2010, 7:22.
33. Stone V., Johnston H., Schins R.P. Development of in vitro systems for nanotoxicology: methodological considerations. Crit. Rev. Toxicol. 2009, 39:613-626.
34. 2+ dependent protein kinase. Biochem. Biophys. Res. Commun. 1986, 135:397-402.
35. Unfried K., Albrecht C., Klotz L.-O., Von Mikecz A., Grether-Beck S., Schins R. Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 2007, 1:52-71.
36. Valko M., Morris H., Cronin M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12:1161-1208.
37. 2 nanoparticles: studies on a human monoblastoid cell line. Toxicol. In Vitro 2008, 22:1689-1696.
38. van Engeland M., Nieland L.J., Ramaekers F.C., Schutte B., Reutelingsperger C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998, 31:1-9.
39. Xia T., Kovochich M., Liong M., Madler L., Gilbert B., Shi H., Yeh J.I., Zink J.I., Nel A.E. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS nano. 2008, 2:2121-2134.
40. 2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells. Part Fibre Toxicol. 2010, 7:1.
41. 2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. Toxicol. In Vitro 2010, 24:751-758.